» Articles » PMID: 33688194

Short- and Long-Term Effects of Vitamin D Treatment on Bacillus Calmette-Guerin-Induced Depressive-Like Behavior in Mice

Abstract

Purpose: Depression is one of the most common psychological disorders. The nutritional etiology of the depression proposes that vitamin D may play a significant role in the pathogenesis of depression. Further, vitamin D deficiency has been found to aggravate depression in animals. Therefore, vitamin D treatment might be a potential therapeutic aid in depression management. This study aimed to explore the antidepressant effects of vitamin D in a Bacillus Calmette-Guerin (BCG)-induced depression model.

Methods: Thirty-six mice were randomly assigned to short-term and long-term experimental groups. In each group, mice were randomly subcategorized into three subgroups: 1. control (received vehicle), 2. BCG (received BCG [10 CFU/mouse]), and 3. BCG + vitamin D (received vitamin D [60.000 IU/kg] before BCG [10 CFU/mouse] inoculation). After completion of the two experimental periods (3 days for the short-term group and 2 weeks for the long-term group), the mice underwent three behavioral tests: locomotor activity, the forced swimming test (FST), and the tail suspension test (TST).

Results: Locomotor activity did not significantly differ among the subgroups in either the long-term or short-term groups. In the short-term group, the total immobility time on the FST was decreased in the vitamin D-treated group compared to the BCG group. However, in the TST, no significant difference was found between the vitamin D-treated group and the BCG group. In the long-term group, the immobility time on the FST was decreased in the vitamin D-treated group compared to the BCG group. Similarly, the total immobility time on the TST was also significantly lower in the vitamin D-treated mice than in the BCG-treated mice.

Conclusion: Vitamin D is useful in the management of depressive behavior. The potential role of vitamin D in the etiology of depression should be investigated in future work.

Citing Articles

Preventive and therapeutic effect of vitamin D on depression-like behavior in a mouse adolescent depression model and its association with BDNF protein expression.

Yang X, Miao J, Huang Y, Li L, Zhuang G Front Psychiatry. 2024; 15:1425681.

PMID: 39135986 PMC: 11317463. DOI: 10.3389/fpsyt.2024.1425681.

References
1.
Brown J, Bianco J, McGrath J, Eyles D . 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett. 2003; 343(2):139-43. DOI: 10.1016/s0304-3940(03)00303-3. View

2.
Chen B, Dowlatshahi D, MacQueen G, Wang J, Young L . Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001; 50(4):260-5. DOI: 10.1016/s0006-3223(01)01083-6. View

3.
Meltzer H . Role of serotonin in depression. Ann N Y Acad Sci. 1990; 600:486-99; discussion 499-500. DOI: 10.1111/j.1749-6632.1990.tb16904.x. View

4.
Khoraminya N, Tehrani-Doost M, Jazayeri S, Hosseini A, Djazayery A . Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust N Z J Psychiatry. 2012; 47(3):271-5. DOI: 10.1177/0004867412465022. View

5.
Holsboer F . The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000; 23(5):477-501. DOI: 10.1016/S0893-133X(00)00159-7. View